Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Agomelatine versus placebo for obsessive-compulsive disorder
NL-OMON34855Phase 2Not yet recruiting
- Sponsor
- Servier
- Start
- Apr 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in obsessive compulsive disorder (OCD) comparing Agomelatine with Placebo (2 arms). Primary endpoint: Yale-Brown Obsessive Compulsive Scale total score. Planned start Apr 2010; status: not yet recruiting.
02
Drugs
agomelatine
03
Conditions
obsessive compulsive disorder (OCD)
Beyond the preview
Go deeper on NL-OMON34855.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON34855.